Search results
Results From The WOW.Com Content Network
(Reuters) -Edwards Lifesciences on Monday said it has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion to sharpen focus on its heart ...
Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. ... The analyst also highlights that the sale of Edwards’ Critical Care business to Becton, Dickinson and ...
BD's (BDX) core Life Sciences arm is expected to have driven first-quarter performance. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways ...
The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.It later moved its headquarters to New Jersey. In 2004, BD agreed to pay out US$100 million to settle allegations from competitor Retractable Technologies that it had engaged in anti-competitive behavior to prevent the distribution of Retractable's syringes, which are designed to prevent needlestick ...
Becton, Dickinson and Company headquarters; C. CareFusion This page was last edited on 9 August 2020, at 21:07 (UTC). Text is available under the Creative Commons ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
Becton's stock rose as high as $287.32, topping the previous intra-day record of $279.38 hit in February 2020. The 510(k) clearance enables the company to resume selling its Alaris infusion system.
Henry "Hank" Prentiss Becton (September 15, 1914 – October 25, 2009) was an American business executive and philanthropist. [1] He was the chairman of Becton Dickinson and Company.